Continuous overexpression of NOX4 has been observed in breast cancer, colorectal cancer, clear cell renal cell carcinoma, and lung cancer compared to normal tissues, suggesting its potential as a universal cancer biomarker. The gene discussed is NOX4; the disease is lung carcinoma.